Nano-X Imaging (NNOX) Asset Writedowns and Impairment (2021 - 2024)
Nano-X Imaging's (NNOX) quarterly Asset Writedowns and Impairment came in at $86000.0 in Q4 2024, down 98.78% YoY from $7.1 million in Q1 2024, and up 256.36% on a QoQ basis from -$55000.0 in Q3 2024.
Nano-X Imaging (NNOX) Asset Writedowns and Impairment (2021 - 2024) Analysis & Trends
Nano-X Imaging (NNOX) has 4 years of Asset Writedowns and Impairment data on file, last reported at $86000.0 in Q4 2024.
- Quarterly Asset Writedowns and Impairment fell 98.78% year-over-year to $86000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $202000.0 (down 97.46% YoY) and the FY2025 annual result came in at $17.5 million, up 8577.23% from the prior year.
- Asset Writedowns and Impairment grew to $86000.0 in Q4 2024, from -$55000.0 in the prior quarter.
- In the past five years, Asset Writedowns and Impairment ranged from a high of $36.5 million in Q4 2022 to a low of -$55000.0 in Q3 2024.
- A 4-year average of $5.4 million and a median of $145000.0 in 2023 frame the typical range for Asset Writedowns and Impairment.
- Annual changes were most pronounced in 2022 — Asset Writedowns and Impairment jumped 91250.0% — and 2024, when it tumbled 107.45%.
- Tracing NNOX's Asset Writedowns and Impairment over 4 years: stood at $40000.0 in 2021, then jumped by 91250.0% to $36.5 million in 2022, then plunged by 80.69% to $7.1 million in 2023, then tumbled by 98.78% to $86000.0 in 2024.
- The last three Asset Writedowns and Impairment figures came in at $86000.0 (Q4 2024), -$55000.0 (Q3 2024), and $146000.0 (Q2 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn |
| 10 | Nano-X Imaging | 61,661.55 | -44.16 Mn | -2.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 86,000.00 |
| Dec 31, 2024 | 86,000.00 |
| Sep 30, 2024 | -55,000.00 |
| Sep 30, 2024 | -55,000.00 |
| Jun 30, 2024 | 146,000.00 |
| Jun 30, 2024 | 146,000.00 |
| Mar 31, 2024 | 25,000.00 |
| Mar 31, 2024 | 25,000.00 |
| Dec 31, 2023 | 7.06 Mn |
| Dec 31, 2023 | 7.06 Mn |
| Sep 30, 2023 | 738,000.00 |
| Sep 30, 2023 | 738,000.00 |
| Mar 31, 2023 | 145,000.00 |
| Mar 31, 2023 | 145,000.00 |
| Dec 31, 2022 | 36.54 Mn |
| Dec 31, 2022 | 36.54 Mn |
| Jun 30, 2022 | 14.34 Mn |
| Jun 30, 2022 | 14.34 Mn |
| Mar 31, 2022 | 28,000.00 |
| Mar 31, 2022 | 28,000.00 |